CClinicalTrials.gg
RecruitingNCT07799142Updated Sep 11, 2026

Femoral Stretch Test in L2-L4 Lumbar Radiculopathy

An observational study in Lumbar Radiculopathy, sponsored by Marmara University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Months and older. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by Marmara University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
18 Months and older
Sex
All
01

Study summary

This prospective observational study aims to evaluate the sensitivity of the femoral stretch test in patients with unilateral, single-root L2, L3, or L4 nerve root compression and to determine whether test positivity differs according to the affected nerve root.

Patients with unilateral radicular symptoms and magnetic resonance imaging-confirmed single-root compression involving the L2, L3, or L4 nerve root who are scheduled to undergo transforaminal epidural steroid injection as part of routine clinical care will be included. The decision to perform transforaminal epidural steroid injection will be made independently of participation in the study.

Before the procedure, the femoral stretch test, pain intensity, neuropathic pain characteristics, dermatomal concordance of symptoms, and relevant magnetic resonance imaging findings will be recorded. The femoral stretch test and pain intensity will be reassessed 1 hour after the procedure. The study will primarily evaluate the sensitivity of the femoral stretch test for L2, L3, and L4 nerve root involvement and will also assess changes in test findings following transforaminal epidural steroid injection.

02

Conditions studied

  • Lumbar Radiculopathy

Browse trials for

Keywords

  • transforaminal epidural injection
  • femoral strecth test
03

Who can participate

Ages eligible
18 Months and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients with lumbar radicular pain who are evaluated at a tertiary pain medicine clinic and are scheduled to undergo clinically indicated single-level, unilateral transforaminal epidural steroid injection targeting the L2, L3, or L4 nerve root will be prospectively enrolled.

Inclusion criteria

  • Patients with a diagnosis of lumbar radicular pain based on medical history, physical examination, and imaging findings.
  • Patients with unilateral L2, L3, or L4 nerve root involvement who are scheduled to undergo single-level, unilateral transforaminal epidural steroid injection targeting the corresponding nerve root.

Exclusion criteria

Exclusion Criteria:

  • Presence of diabetes mellitus or other medical conditions that may cause polyneuropathy.
  • Presence of active radicular pain originating from lumbosacral nerve roots other than L2, L3, or L4.
  • Unavailability of relevant radiological imaging.
  • Cognitive impairment that may interfere with clinical assessment.
  • Pregnancy.
  • Presence of local or systemic infection.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • L2 Nerve Root Compression Cohort

    Patients with unilateral, magnetic resonance imaging-confirmed single-root L2 nerve root compression and clinically concordant radicular symptoms who are scheduled to undergo transforaminal epidural steroid injection as part of routine clinical care. Femoral stretch test findings and pain intensity will be recorded before and after the procedure.

  • L3 Nerve Root Compression Cohort

    Patients with unilateral, magnetic resonance imaging-confirmed single-root L3 nerve root compression and clinically concordant radicular symptoms who are scheduled to undergo transforaminal epidural steroid injection as part of routine clinical care. Femoral stretch test findings and pain intensity will be recorded before and after the procedure.

  • L4 Nerve Root Compression Cohort

    Patients with unilateral, magnetic resonance imaging-confirmed single-root L4 nerve root compression and clinically concordant radicular symptoms who are scheduled to undergo transforaminal epidural steroid injection as part of routine clinical care. Femoral stretch test findings and pain intensity will be recorded before and after the procedure.

05

What researchers measure

Primary outcomes

  1. Root-Level Sensitivity of the Femoral Stretch Test for L2, L3, and L4 Nerve Root Compression

    The sensitivity of the femoral stretch test will be calculated separately in patients with unilateral, Magnetic Resonance Imaging-confirmed single-root L2, L3, and L4 nerve root compression. Root-level sensitivities will be compared to determine whether the diagnostic sensitivity of the test differs according to the affected nerve root.

    Time frame: Baseline

Secondary outcomes

  1. Change in Femoral Stretch Test Positivity Following Transforaminal Epidural Steroid Injection

    Femoral stretch test results will be recorded as positive or negative immediately before and after transforaminal epidural steroid injection. The proportion of patients with a change from a positive to a negative test following the procedure will be evaluated overall and according to the affected nerve root (L2, L3, and L4).

    Time frame: Baseline and 1 hour post-procedure

  2. Change in Pain Intensity Following Transforaminal Epidural Steroid Injection

    Pain intensity will be assessed using the Numeric Rating Scale, ranging from 0 (no pain) to 10 (worst imaginable pain), immediately before and after transforaminal epidural steroid injection. The change in Numeric Rating Scale score following the procedure will be evaluated.

    Time frame: Baseline and 1 hour post-procedure

  3. Association Between Femoral Stretch Test Positivity and Magnetic Resonance Imaging Nerve Root Compression Severity

    The association between pre-procedural femoral stretch test positivity and the severity of nerve root compression on lumbar magnetic resonance imaging will be evaluated in patients with unilateral, single-root L2, L3, or L4 nerve root compression.

    Time frame: Baseline

  4. Association Between Femoral Stretch Test Positivity and Neuropathic Pain Characteristics

    Neuropathic pain characteristics will be assessed using the 10-item DN4 neuropathic pain questionnaire, a validated screening tool for neuropathic pain. The total score ranges from 0 to 10, with higher scores indicating a greater likelihood of neuropathic pain. The association between the pre-procedural DN4 score and femoral stretch test positivity will be evaluated in patients with unilateral, single-root L2, L3, or L4 nerve root compression.

    Time frame: Baseline

06

Study locations

1 of 1 sites recruiting
  • Marmara University Pendik Training and Research Hospital
    Istanbul, Pendik 34899, Turkey (Türkiye)
    Recruiting
07

References and documents

Individual participant data

Plan to share: No — Individual participant data are not planned to be shared publicly due to participant confidentiality and data protection considerations.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07799142
Lead sponsor
Marmara University
Responsible party
Nurbanu Hindioglu Dogan (Principal Investigator, Marmara University) — Principal investigator
First posted
Sep 2, 2026
Start date
Sep 7, 2026
Primary completion
Mar 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Sep 11, 2026

Study contacts

Nurbanu Hindioglu Dogan, MD
Contact
nurbanuhindioglu@gmail.com
+902166254545

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion